Herpes Zoster Ophthalmicus

Table of contents
Article 🔍
A comprehensive topic overview

Introduction

Herpes zoster ophthalmicus (HZO) refers to shingles a
HZO accounts for 10-20% of all shingles, which itself has a lifetime incidence of 30%, contributing signi
health burden.
1,2
HZO can involve any part of the eye or orbit, ranging from potentially benign, to sight- or life-threatening complications.

Aetiology

Varicella zoster virus (VZV), like herpes simplex virus (HSV), is also a dsDNA virus of the herpes group.
Primary infection with VZV manifests as chickenpox (varicella). Following resolution, viruses establish latent infection
within sensory nerve ganglions. Reactivation of such dormant viruses results in shingles (herpes zoster). Involvement of the
ophthalmic branch of the trigeminal nerve (V1) results in herpes zoster ophthalmicus (HZO).
Individuals with no previous VZV infection may contract chickenpox from those with shingles. Transmission is by direct
contact or droplet spread.

Risk factors

The incidence and severity of HZO increase with advancing age, with a sharp increase in incidence in individuals aged 60
1
and above . Other groups at risk of severe infection include\:
Immunosuppressed (e.g. HIV, chemotherapy)
Pregnant patients
Neonates
Ocular involvement occurs in approximately 50% of patients with HZO. There is no correlation between the severity of skin
rash and the extent of ocular complications.

Clinical features

History3
Typical symptoms of HZO include\:
Viral prodromal phase\: fever, malaise, headache
Pre-herpetic neuralgia\: paraesthesia and pain along the a
one month after the rash has healed, it is termed post-herpetic neuralgia.
Rash\: a characteristic, unilateral rash following the dermatomal distribution of V1
Zoster sine herpete\: neuropathic pain not accompanied by a characteristic rash
HZO may involve any part of the globe or none. Symptoms may vary depending on the structures a
guide clinical examination\:Isolated conjunctivitis and corneal involvement present with mildly reduced visual acuity, red eye, sharp pain, foreign
body sensation and epiphora
The presence of photophobia, dull eye pain and new
opinion. This may be 1-3 weeks following the onset of the rash.
Symptoms of diplopia may indicate associated extraocular muscle palsy.
Clinical examination3
Patients with suspected HZO should undergo a comprehensive examination including visual acuity testing, colour vision
assessment, anterior segment examination (using an Arclight or a direct ophthalmoscope on +10 lens setting), slit lamp
examination, fundoscopy, and testing of extra-ocular eye muscles.
Patients with suspected cerebral involvement should undergo a full neurological examination.
Typical clinical
Eyelid erythema and oedema (may be severe)
Skin lesions in the following chronological order\: macules-> papules -> vesicles -> pustules -> crusted lesions in the
upper lid and along the rest of the V1 dermatomal distribution
Conjunctiva\: di
Cornea\:
pseudodendrites (lacks terminal bulbs as in HSV)
Signs of anterior uveitis and posterior segment involvement (retinitis, optic neuritis etc)
Cranial nerve palsy
Reduced corneal sensation
Hutchinson’s sign
Hutchinson's sign refers to cutaneous lesions on the tip, side or root of the nose which indicates involvement of the V1
nasal branch. This is a strong predictor of ocular involvement.
Figure 1. Herpes zoster ophthalmicus.
This photograph demonstrates the
characteristic distribution of rash
involving the V1 dermatome with
associated right upper eyelid oedema.

Investigations

The diagnosis of HZO is clinical in the vast majority of cases with the identi
Relevant investigations may include\:
Conjunctival or skin swabs of lesions can be sent for con
Suspected cerebral involvement (rare) will require neuroimaging and/or lumbar puncture

Management

All cases of HZO with intraocular involvement should be promptly referred to an ophthalmologist.Antiviral therapy
Antiviral therapy is the mainstay of treatment of HZO. When given within 72 hours of the onset of the rash, it decreases the
severity and duration of both the acute illness and post-herpetic neuralgia.
4
Concurrent use of oral steroids may confer additional bene
the rash. However oral steroids do not decrease the incidence or severity of post-herpetic neuralgia.
5
A typical antiviral regimen would be oral aciclovir 800mg
three times a day may be used. Severe cases may require intravenous therapy.
Supportive treatment
Supportive treatments such as cold compresses, oral analgesics and topical preservative-free lubricants should be
prescribed.
Severe pain and post-herpetic neuralgia may bene
gabapentin. 4
A referral to a specialist pain clinic may be required for some patients.
Other therapy
Topical steroids, cycloplegics and intraocular pressure lowering drops are used in cases with deeper ocular involvement
(e.g. in stromal keratitis and uveitis). Oral steroids are indicated in the treatment of certain intraocular manifestations such as
retinitis.
Follow-up of HZO should be tailored to the individual patient, depending on the extent, severity and chronicity of their
symptoms.

Complications

Complications of HZO include\:
Postherpetic neuralgia\: the most common complication, a
Repeat corneal ulcers following resolution of the acute episode, resulting in corneal thinning and perforation
Vision-threatening involvement of the posterior segment of the eye (e.g. acute retinal necrosis, progressive outer retinal
necrosis and optic neuritis)
Cranial nerve palsy of the nerves supplying the extraocular muscles\: third, fourth and sixth nerve.
Systemic complications include pneumonitis, encephalitis, vasculitis, stroke and Guillain-Barré syndrome

Key points

Herpes zoster ophthalmicus is the term used to describe shingles a
HZO is a common presentation of shingles (10-20%) and mostly a
HZO is a clinical diagnosis made on the identi
Lesions along the tip, root or side of the nose are a strong predictor of ocular involvement (Hutchinson’s sign).
HZO has a broad range of ocular and systemic manifestations from benign to sight- and life-threatening, therefore
thorough history and neuro-ophthalmic examination are required.
Antiviral therapy and supportive measures are the mainstays of treatment. Signi
prompt referral for specialist advice and treatment.
Post-herpetic neuralgia is the most common long-term complication of HZO and may be challenging to treat in a
subset of patients.

References

Liesegang TJ. Herpes Zoster Ophthalmicus. Natural History, Risk Factors, Clinical Presentation, and Morbidity.
Ophthalmology 2008;115(2 SUPPL.).Curran D, Callegaro A, Fahrbach K, et al. Meta-Regression of Herpes Zoster Incidence Worldwide. Infect Dis Ther
2022;11(1)\:389–403.
Kanski JJ, Bowling B. Clinical Ophthalmology\: A Systematic Approach. Edinburgh, Elsevier/Saunders; 2015.
Dworkin RH, Schmader KE, Goldstein EJC. Treatment and Prevention of Postherpetic Neuralgia. Clinical Infectious Diseases
[Internet] 2003;36(7)\:877–82.
Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A Randomized Trial of Acyclovir for 7 Days or 21
Days with and without Prednisolone for Treatment of Acute Herpes Zoster. New England Journal of Medicine [Internet]
1994;330(13)\:896–900.
Image references
Figure 1. BurntCC BY-SA 4.0 via Wikimedia Commons

Reviewer

Dr Vishal Vohra

Related notes

Acute Angle-Closure Glaucoma
Age-related Macular Degeneration (ARMD)
Amblyopia
Ametropia
Anisocoria

Test yourself

Contents

Introduction
Aetiology
Risk factors
Clinical features
Investigations
Management
Complications
Source\: geekymedics.com